Regeneron Pharmaceuticals Inc vs Johnson & Johnson
REGN vs JNJ — side-by-side comparison from reported financials. REGN leads 5, JNJ leads 5 of 10 comparable metrics.
Regeneron Pharmaceuticals Inc
REGN · Healthcare
$745.55+0.81%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | REGN | JNJ |
|---|---|---|
| Price | $745.55 | $261.79 |
| Market cap | $76.8B | $631B |
| Revenue (TTM) | $15.5B | $97.9B |
| Revenue growth | +5.6% | +5.6% |
| Net margin | 27.9% | 21.5% |
| Free cash flow | $3.76B | $22.2B |
| Net cash (debt) | $6.62B | ($27.8B) |
| 1-year price return | +30.8% | +37.0% |
| P/E | 17.8 | 29.9 |
| P/E vs own history (cheap-side %) | 46% | 16% |
| Dividend yield | 0.49% | 2.00% |
| Return on equity | 14% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 15,410 | 140,800 |
Full résumé-style profiles: REGN CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.